deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT06689553

Percutaneously Delivered Automated Continual Fluid Removal System in Patients With Advanced Diuretic-Resistant Heart Failure (CLEAR-HF)

A Multi-Center, Multinational, Prospective, Open-Label, Single Arm, Pilot Study to Assess the Feasibility, Safety and Tolerability of a Percutaneously Delivered Automated Continual Fluid Removal System in Patients With Advanced Diuretic-Resistant Heart Failure

Sponsor: Paragate Medical LTD

Conditions Heart Failure
Interventions Automated Continual Fluid Removal System
Updated 4 times since 2024 Last updated: Jul 28, 2025 Started: Sep 28, 2025 Primary completion: Jul 30, 2026 Completion: Dec 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Heart Failure and is currently actively recruiting participants. Paragate Medical LTD leads this study, which shows 4 recorded versions since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Dec 2024 – ~Jan 2025 · 31 days · monthly snapshot~Jan 2025 – ~Jun 2025 · 5 months · monthly snapshotNot Yet Recruiting~Jun 2025 – ~Aug 2025 · 2 months · monthly snapshotRecruiting~Aug 2025 – present · 11 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Aug 2025 — Present [monthly]

    Recruiting NA

  2. Jun 2025 — Aug 2025 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  3. Jan 2025 — Jun 2025 [monthly]

    Not Yet Recruiting NA

  4. Dec 2024 — Jan 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Paragate Medical LTD
Data source: Paragate Medical LTD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations